skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: You recommended CELH as recently as yesterday (Sept 4), a day when it plunged more than 11% in the afternoon. Normally you don’t seem to favour stocks with very weak price action. Should investors keep making an exception for CELH? Is there a price level at which point you’d consider it too broken to buy?
Read Answer Asked by Brian on September 05, 2024
Q: The PE for this stock currently is around 43 and analysts are forecasting 30.5%/yr. growth in earnings over each of the next 5 years. Everything I read suggests this mag 7 stock is poised to go up and do phenomenal. To grow EPS 30.5%/yr for each of the next 5 years seems extremely optimistic to start with but even if it does the PEG ratio is 1.41 which suggests over valuation. The other mag 7 stocks with the exception of NVDA have much lower EPS growth rates at 20% max and dropping from there. How can one rationalize buying this stock now. Thank you. John
Read Answer Asked by John on September 05, 2024
Q: Morning, you wonderful people.

Looking to add with your help. I am a believer in tech and growth in my TFSA. Other accounts are balanced.

I hold CSU, AMZN, NVDA, MSFT, GOOG, COST, AVGO, BRK.B, BLK.

Regardless of sector etc. Please let me know your top 3-5 to add to this portfolio. Longterm and conviction!

Thank you muchly.
Read Answer Asked by Jemma on September 04, 2024
Q: Looking for a 5 year hold for a small position. Which of these, if any, do you suggest? Is this a promising area to invest in and are there others you prefer?
Read Answer Asked by Graeme on September 03, 2024
Q: Is there a US equivalent of CSU that you would recommend as I take profits from growthier AI stocks? Happy to split it between a few stocks, but the big 7 have grown as a large part of my US portfolio.
Read Answer Asked by Dave on September 03, 2024
Q: Hi team,

What is your analysis of National Health Care (NHC-N) and Altimmune (ALT-Q) ?

Gratefully,

Jacques IDS
Read Answer Asked by Jacques on September 03, 2024
Q: What are your thoughts on their strong Q2 earnings? Would this be a good entry point? It may finally be ready to rally over the next quarter.
Read Answer Asked by Neeraj on September 03, 2024
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!